We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Brunswick
BC
$5.28B
| $1.65M | 0.01% |
25,246
-11,052
| -30% | -$829K |
|
552
ArcBest
ARCB
$3.27B
| $1.65M | 0.01% |
22,706
-1,200
| -5% | -$96.5K |
|
553
Avantor
AVTR
$9.3B
| $1.65M | 0.01% |
84,055
+68,559
| +442% | +$1.84M |
|
|
RUTH
554
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $1.63M | 0.01% |
+96,616
| New | +$1.71M |
|
|
STEL
555
DELISTED
Stellar Bancorp
STEL
| $1.62M | 0.01% |
55,258
+30,862
| +127% | +$928K |
|
556
Corcept Therapeutics
CORT
$12B
| $1.61M | 0.01% |
62,996
+29,214
| +86% | +$782K |
|
557
Quanex
NX
$978M
| $1.61M | 0.01% |
88,642
+37,220
| +72% | +$842K |
|
558
Ingevity
NGVT
$2.61B
| $1.6M | 0.01% |
26,395
-1,000
| -4% | -$67.1K |
|
|
LSXMK
559
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $1.59M | 0.01% |
54,613
-82,988
| -60% | -$2.58M |
|
560
Haverty Furniture Companies
HVT
$445M
| $1.59M | 0.01% |
63,917
| – | – |
|
561
Universal Insurance Holdings
UVE
$1.18B
| $1.59M | 0.01% |
161,492
-20,508
| -11% | -$246K |
|
562
Range Resources
RRC
$9.28B
| $1.59M | 0.01% |
62,940
+37,764
| +150% | +$1.14M |
|
563
Ironwood Pharmaceuticals
IRWD
$682M
| $1.59M | 0.01% |
153,308
+93,835
| +158% | +$1.06M |
|
564
Ameriprise Financial
AMP
$49.9B
| $1.59M | 0.01% |
6,294
-393
| -6% | -$103K |
|
565
Yelp
YELP
$1.28B
| $1.58M | 0.01% |
+46,589
| New | +$1.54M |
|
566
Kiniksa Pharmaceuticals
KNSA
$6.08B
| $1.58M | 0.01% |
122,990
+57,408
| +88% | +$654K |
|
567
Ameris Bancorp
ABCB
$5.98B
| $1.56M | 0.01% |
34,920
+11,770
| +51% | +$540K |
|
568
Titan Machinery
TITN
$422M
| $1.56M | 0.01% |
55,188
+32,500
| +143% | +$921K |
|
569
Qorvo
QRVO
$8.66B
| $1.56M | 0.01% |
19,632
-2,429
| -11% | -$235K |
|
570
Modine Manufacturing
MOD
$10.9B
| $1.56M | 0.01% |
120,345
+23,890
| +25% | +$335K |
|
571
Celanese
CE
$4.82B
| $1.55M | 0.01% |
17,216
-3,753
| -18% | -$412K |
|
572
Resources Connection
RGP
$145M
| $1.55M | 0.01% |
85,987
-22,635
| -21% | -$454K |
|
573
Atkore
ATKR
$3.17B
| $1.54M | 0.01% |
19,805
+411
| +2% | +$35.5K |
|
574
Coty
COTY
$2.42B
| $1.53M | 0.01% |
242,947
-60,451
| -20% | -$457K |
|
575
Essential Properties Realty Trust
EPRT
$6.7B
| $1.53M | 0.01% |
78,941
+51,943
| +192% | +$1.18M |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.